• No results found

Dopamine D2 receptors in the pathophysiology of insulin resistance Leeuw van Weenen, J.E. de

N/A
N/A
Protected

Academic year: 2021

Share "Dopamine D2 receptors in the pathophysiology of insulin resistance Leeuw van Weenen, J.E. de"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Dopamine D2 receptors in the pathophysiology of insulin resistance

Leeuw van Weenen, J.E. de

Citation

Leeuw van Weenen, J. E. de. (2011, October 5). Dopamine D2 receptors in the

pathophysiology of insulin resistance. Retrieved from https://hdl.handle.net/1887/17899

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/17899

Note: To cite this publication please use the final published version (if applicable).

(2)

Dopamine D2 receptors in the pathophysiology of insulin resistance

Judith Carlier-de Leeuw van Weenen

(3)
(4)

Dopamine D2 receptors in the pathophysiology of insulin resistance

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden,

op gezag van Rector Magnificus prof. mr. P.F. van der Heijden, volgens besluit van het College voor Promoties

te verdedigen op woensdag 5 oktober 2011 klokke 15.00 uur

door

Judith Elisabeth de Leeuw van Weenen geboren te Zürich (Zwitserland)

in 1980

(5)

Promotiecommissie

Promotor: Prof. dr. H. Pijl

Overige leden: Prof. dr. A.J.W. Scheurink (Universiteit Groningen) Prof. dr. J.A. Romijn (AMC, Amsterdam)

Prof. dr. E.R. de Kloet Dr. B. Guigas

The work described in this thesis was performed at the department of Endocrinology and Metabolic Diseases at the Leiden University Medical Center, Leiden, the Netherlands.

The project was financially supported by a grant from the Dutch Diabetes Research Foundation (project 2002.01.005).

(6)
(7)

Colophon

© J.E. Carlier-de Leeuw van Weenen, 2011

All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means without the prior written permission of the author.

ISBN 978 94 6108 193 3

Printed by Gildeprint Drukkerijen

The printing of this thesis was financially supported by:

The Dutch Diabetes Research Foundation J.E. Jurriaanse Stichting

Novo Nordisk B.V.

Novartis Pharma B.V.

Research Diet Services B.V.

(8)

Table of contents

Chapter 1 9

General Introduction

Chapter 2 37

Four weeks high fat feeding induces insulin resistance without affecting dopamine release or gene expression patterns in the hypothalamus of C57Bl6 mice

Brain Research 2009; 1250: 141-148

Chapter 3 55

Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high fat diet induced obese mice

Journal of Neuroendocrinology 2011; 23: 158-167

Chapter 4 75

Pharmacological modulation of dopamine receptor D2 mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice

Experimental Diabetes Research 2011; 2011: 928523

Chapter 5 93

Effects of olanzapine and haloperidol on the metabolic status of healthy menJournal of Clinical Endocrinology and Metabolism 2010; 95: 118-125

Chapter 6 109

The dopamine receptor D2 agonist bromocriptine inhibits glucose- stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

Biochemical Pharmacology 2010; 79: 1827-1836

Chapter 7 133

General Discussion

Chapter 8 149

Summary Samenvatting List of Abbreviations

Curriculum Vitae and Publications 162 Dankwoord 164

(9)

Referenties

GERELATEERDE DOCUMENTEN

Agouti-Gene-Related Protein Ad Libitum AMP-activated Protein Kinase Antipsychotic Adrenergic Receptor Nucleus Arcuatus Area Under the Curve Bromocriptine Body Mass Index Body

Injection of bromocriptine directly into the brain of diabetic hamsters, in a concentration that does not have an effect when administered systemically, also diminishes body

We monitored in vivo dopamine release in the dorsomedial region of the hypothalamus and determined hypothalamic gene expression patterns of dopamine receptors 1 and 2 DRD1 and

The glucose infusion rate, necessary to maintain Figure 2 - Plasma glucose (A) and insulin (C) concentration during the intraperitoneal glucose tolerance test in AL and CR

Haloperidol treatment reduced the voluntary activity and energy expenditure of DR mice and induced insulin resistance in these mice.. Conversely, bromocriptine treatment tended

De volgende conclusies met betrekking tot het laagcalorisch dieet in obese DM2 kunnen worden getrokken: 1) het is veilig om een VLCD aan deze groep patiënten te geven;

Two days of a very low calorie diet reduces endogenous glucose production in obese type 2 diabetic patients despite the withdrawal of blood glucose lowering therapies

De snelle daling van de bloedsuikerwaarden na het starten van een zeer laag- calorisch dieet in obese patiënten met type 2 diabetes mellitus berust op een